Millennium Management
TBIO

Millennium Management’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

Millennium Management’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-12,911
Closed -$47.1K – 6593
2024
Q2 		$47.1K Hold
12,911
– – ﹤0.01% 5426
2024
Q1 		$102K Sell
12,911
-3,618
-22% -$27.2K ﹤0.01% 5575
2023
Q4 		$119K Buy
16,529
+3,225
+24% +$35.8K ﹤0.01% 5302
2023
Q3 		$249K Sell
13,304
-678
-5% -$16.5K ﹤0.01% 5019
2023
Q2 		$398K Sell
13,982
-5,132
-27% -$205K ﹤0.01% 4706
2023
Q1 		$1.07M Sell
19,114
-711
-4% -$25.2K ﹤0.01% 4032
2022
Q4 		$446K Sell
19,825
-465
-2% -$12.6K ﹤0.01% 4825
2022
Q3 		$606K Sell
20,290
-3,800
-16% -$134K ﹤0.01% 4790
2022
Q2 		$781K Buy
24,090
+10,191
+73% +$704K ﹤0.01% 4599
2022
Q1 		$1.34M Sell
13,899
-56,325
-80% -$8.54M ﹤0.01% 4250
2021
Q4 		$13.7M Buy
70,224
+32,648
+87% +$5.08M 0.01% 1811
2021
Q3 		$7.53M Sell
37,576
-2,139
-5% -$543K ﹤0.01% 2403
2021
Q2 		$15.7M Buy
+39,715
New +$14M 0.01% 1436

Other funds holding TBIO

CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Millennium Management's TBIO Position: Q3 2024 in Review

Millennium Management sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q3 2024, closing a stake of 12,911 shares — an estimated $47.1K sold.

Millennium Management first reported a position in TBIO in Q2 2021 and held it in 13 quarters. The position peaked at $15.7M in Q2 2021. 1 fund tracked by Wall St. Rank holds TBIO as of Q3 2024.

  • Millennium Management reported no remaining Telesis Bio, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Millennium Management sold 12,911 Telesis Bio, Inc. Common Stock shares in Q3 2024, an estimated $47.1K.
  • Millennium Management first reported a position in Telesis Bio, Inc. Common Stock in Q2 2021 and held it in 13 quarters.
  • Millennium Management's Telesis Bio, Inc. Common Stock position peaked at $15.7M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q3 2024.

Based on Millennium Management's 13F filing for Q3 2024, filed 14 Nov 2024.